Tolerability Of As-Needed Treatment With Budesonide And Formoterol Combination In Adult Patients With Mild Asthma

被引：0
|
作者：
Tanaka, A. [1 ]
Ohta, S. [1 ]
Yamamoto, M. [1 ]
Jinno, M. [1 ]
Miyata, Y. [1 ]
Hirai, K. [1 ]
Yamaguchi, M. [1 ]
Homma, T. [1 ]
Suzuki, S. [1 ]
Yokoe, T. [1 ]
Sagara, H. [1 ]
机构：
[1] Showa Univ, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3199
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Positioning As-needed Budesonide-Formoterol for Mild Asthma Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2
    Bateman, Eric D.
    O'Byrne, Paul M.
    FitzGerald, J. Mark
    Barnes, Peter J.
    Zheng, Jinping
    Lamarca, Rosa
    Puu, Margareta
    Parikh, Himanshu
    Alagappan, Vijay
    Reddel, Helen K.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (12) : 2007 - 2017
  • [22] Cost-effectiveness of as-needed budesonide-formoterol versus over-the-counter as-needed inhaled epinephrine in adults with mild asthma in the US
    Ho, Joseph
    Shaker, Marcus
    Greenhawt, Matthew
    Sadatsafavi, Mohsen
    Abrams, Elissa
    Oppenheimer, John
    Johnson, Kate
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB229 - AB229
  • [23] Asthma control in Greek patients receiving FDC of Budesonide/Formoterol as maintenance and/or as-needed treatment. The NOTOS study
    Rovina, Nikoletta
    Samitas, Konstantinos
    Krommidas, Georgios
    Latsios, Dimitrios
    Bertoli, Maria
    Ginis, Alexandros
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [24] Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma
    O'Byrne, Paul M.
    FitzGerald, J. Mark
    Bateman, Eric D.
    Barnes, Peter J.
    Zhong, Nanshan
    Keen, Christina
    Jorup, Carin
    Lamarca, Rosa
    Ivanov, Stefan
    Reddel, Helen K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (20): : 1865 - 1876
  • [25] Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma
    Beasley, Richard
    Holliday, Mark
    Reddel, Helen K.
    Braithwaite, Irene
    Ebmeier, Stefan
    Hancox, Robert J.
    Harrison, Tim
    Houghton, Claire
    Oldfield, Karen
    Papi, Alberto
    Pavord, Ian D.
    Williams, Mathew
    Weatherall, Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (21): : 2020 - 2030
  • [26] Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies
    J. Mark FitzGerald
    Paul M. O’Byrne
    Eric D. Bateman
    Peter J. Barnes
    Jinping Zheng
    Stefan Ivanov
    Rosa Lamarca
    Ulrika Larsdotter
    Ulrika Emerath
    Gerreke Jansen
    Margareta Puu
    Vijay K. T. Alagappan
    Filip Surmont
    Helen K. Reddel
    Drug Safety, 2021, 44 : 467 - 478
  • [27] Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies
    FitzGerald, J. Mark
    O'Byrne, Paul M.
    Bateman, Eric D.
    Barnes, Peter J.
    Zheng, Jinping
    Ivanov, Stefan
    Lamarca, Rosa
    Larsdotter, Ulrika
    Emerath, Ulrika
    Jansen, Gerreke
    Puu, Margareta
    Alagappan, Vijay K. T.
    Surmont, Filip
    Reddel, Helen K.
    DRUG SAFETY, 2021, 44 (04) : 467 - 478
  • [28] An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to- moderate persistent asthma
    Jönsson, B
    Berggren, F
    Svensson, K
    O'Byrne, PM
    RESPIRATORY MEDICINE, 2004, 98 (11) : 1146 - 1154
  • [29] The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK
    FitzGerald, J. Mark
    Arnetorp, Sofie
    Smare, Caitlin
    Gibson, Danny
    Coulton, Karen
    Hounsell, Kirsty
    Golam, Sarowar
    Sadatsafavi, Mohsen
    RESPIRATORY MEDICINE, 2020, 171
  • [30] Comparison of formoterol and terbutaline for as-needed treatment of asthma:: a randomised trial
    Tattersfield, AE
    Löfdahl, CG
    Postma, DS
    Eivindson, A
    Schreurs, AGM
    Rasidakis, A
    Ekstrom, T
    LANCET, 2001, 357 (9252): : 257 - 261
12345